Postbiotics SupplementationPostBioExInNCT06428656
Postbiotics Supplementation, Gut Microbiota Composition, and Exercise-induced Inflammation
A study testing Postbiotics supplementation in people with Postbiotics Supplementation, run by University of Thessaly at 1 site in Greece.
Trial summary
This study will investigate the effect of postbiotics supplementation on gut microbiota (GM) composition, exercise-induced oxidative stress and performance following eccentrically biased exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Postbiotics Supplementation
- What is being tested?
- Postbiotics supplementation
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 15 participants
- Where
- 1 siteGreece
- Study dates
- 1 Jun 2024to 30 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Physically active subjects (VO2max ≥35ml/kg/min)
- Absence of musculoskeletal injury (≥6 months)
- Abstinence from the use of ergogenic supplements (≥1 month)
- Abstinence from anti-inflammatory drugs (≥1 month)
- Abstinence from pre-pro-postbiotic supplements (≥6 months)
- Abstinence from participating in exercise with eccentric content for at least 7 days before exercise
- Abstinence from alcohol and energy drinks before exercise
Who cannot join
- Recent history of musculoskeletal injury (<6 months)
- Use of ergogenic performance supplements (<1 month)
- Taking anti-inflammatory drugs (<1 month)
- Taking pre-pro-postbiotic supplements (<6 months)
- Participation in exercise with eccentric content in the previous 7 days before exercise
- Consumption of alcohol and energy drinks before exercise
Trial locations and contacts
1 site in 1 country.
Greece1 site
Department of Physical Education and Sport Science, Uninersity of Thessaly
Trikala, Thessaly, 42100
About this study
Official title: The Effect of Postbiotics Supplementation on Gut Microbiota Composition and Exercise-induced Inflammation
This study will investigate the effect of postbiotics supplementation on gut microbiota (GM) composition, exercise-induced oxidative stress and performance following eccentrically biased exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Participants will be randomly assigned into one of the two trials: i) Postbiotics supplementation for 4 weeks, ii) Placebo supplementation for 4 weeks. Participants will then perform a 45-min treadmill running at (-15% slope, ~70% VO2max) followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before, as well as 24 h, 48 h and 72 h following exercise, assessment of GM composition and metabolites (short-chain fatty acids), exercise induced muscle damage (EIMD) (delayed onset of muscle soreness, creatine kinase), complete blood count (CBC), blood inflammatory status (tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), blood redox status (total antioxidant capacity, catalase, protein carbonyls, reduced glutathione, oxidized glutathione, and performance (knee-extensors' and knee-flexors' isometric, concentric, eccentric torque, countermovement jump) will be performed. In addition, metabolism (lactic acid) will be assessed before and 4 min following exercise. Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, the participants will repeat the above procedures under the remaining condition. Between conditions, there will be a 14-day washout period. The results of the research will provide important information for coaches and physically active individuals, regarding the effectiveness of postbiotics to favorably change the gut microbiota composition and alleviate gut inflammation, exercise-induced inflammation and oxidative stress, and improve performance after intense exercise.
Read the detailed description
Acute, vigorous and/or unaccustomed eccentric exercise can induce muscle injury and inflammatory reactions, and oxidative stress, but also reduced muscle performance. For this reason, many professional as well as amateur athletes, often consume nutritional supplements such as antioxidants, anticipating to reduce inflammation and oxidative stress after intense exercise.
The human gastrointestinal tract is inhabited by various microorganisms, called the gut microbiome (GM). GM, among other things, contributes to the normal functioning of the immune system, contributes to the production of short-chain fatty acids (SCFAs) and vitamin synthesis as well as the digestion and absorption of food, protects against enteropathogens and regulates inflammatory and redox responses. Recent evidence also suggests that GM may be involved in athletic performance. In contrast, disruption of GM composition (dysbiosis) is characterized by reduced diversity, reduced abundance of health-promoting bacteria, and increased abundance of gram-negative and other pathogenic bacteria and is associated with various metabolic diseases such as obesity, diabetes, and various forms of cancer, systemic inflammation, oxidative stress and reduced performance. Thus, the supplementation of several "biotics" has been emerged as a means to regulate the GM in favor of health-promoting bacteria.
Postbiotics is defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Evidence suggests that supplementation with postbiotics may regulate the GM, and consequently, strengthen the immune system, reduce intestinal permeability, improve antioxidant mechanisms, as well as accelerate recovery after exercise-induced inflammation, enhance adaptations to exercise, and improve performance. However, the scientific data regarding the possible beneficial effect of supplemental administration of postbiotics is limited. More research is needed, in order to determine the role of postbiotics supplementation on GM composition and function, exercise-induced inflammation and redox status, but also on performance after intense exercise.
This study will investigate the potential of postbiotics supplementation to alter the GM composition and affect the recovery of exercise-induced oxidative stress and performance following intense, eccentrically biased acute exercise. The study will be cross-over, randomized, double-blind, controlled, and will be conducted in two cycles. The participants, will be primarily informed regarding the study procedures, as well as the benefits and possible risks, and will sign an informed consent form for participation in the study. Before the experimental procedure, they will be involved in a week of familiarization to the evaluation tests and the exercise protocol, at a low intensity. Participants will undergo baseline measurements: anthropometric characteristics (body height, body mass, body mass index) via a stadiometer-scale (Stadiometer 208; Seca, Birmingham, UK), body composition (amount of body fat, lean body mass, fat mass, bone density) via by dual emission X-ray absorptiometry (DXA, GE-Healthcare, Lunar DPX NT, Belgium), aerobic capacity (VO2max) via an automated online pulmonary gas analyzer (Vmax Encore 29, BEBJO296, Yorba Linda, CA, USA) during a graded exercise protocol on a treadmill (Stex 8025T, Korea), isokinetic strength (isometric, concentric and eccentric torque of the knee extensors and knee flexors) on an isokinetic dynamometer (Cybex, HUMAC NORM 360, Ronkonkoma, NY), and muscle power via the assessment of countermovement jump (CMJ) via an optical measurement system (Optojump next, Microgate, USA). In addition, the participants will record their diet via a 7-days recall before their participation in the first experimental condition, and dietary data will be analyzed with ScienceFit Diet 200A diet analysis program (Science Technologies, Athens, Greece), in order to estimate that they do not consume nutrients that may affect muscle injury, inflammation and oxidative stress (e.g. antioxidants, etc.). Participants will then be randomized in one of the two conditions: i) Postbiotics supplementation (50mg/day of Heatkilled Lactobacillus plantarum L-137, Immuno-LP20TM) for 4 weeks, or ii) placebo supplementation for 4 weeks. Randomization of the conditions will be done by a software generating random integers available on the internet (Random.org). Participants will then perform an exercise protocol comprised of 45 min downhill running (-15% slope, ~70-75% VO2max) on a treadmill followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before the exercise protocol, as well as 24 h, 48 h and 72 h after exercise, exercise-induced muscle damage (EIMD) [delayed onset of muscle soreness (DOMS) via palpation of the knee extensors and knee flexors on a scale of 1 to 10 (1 = no pain at all; 10 = extreme pain), and muscle performance (CMJ, isometric, concentric and eccentric torque of the knee extensors and knee flexors)], will be assessed. At the same time points, feces samples will be collected for the analysis of GM composition and function, and GM metabolites, as well as blood samples for the assessment of complete blood count (CBC), blood inflammatory status (creatine kinase, tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), and blood redox status [reduced glutathione (GSH), oxidized glutathione (GSSG), GSH/GSSG ratio, total antioxidant capacity, catalase, protein carbonyls, uric acid, bilirubin). Furthermore, metabolism (lactic acid) will be assessed before and 4 min following exercise by analyzing capillary blood with a portable lactate analyzer (Lactate Plus, Nova Biomedical, USA). Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, participants will repeat the exact same procedures for the remaining condition. Between cycles, a 14-days washout period will be applied. Additionally, the 7-day diet recall from the first cycle, will be given to the participants to follow the same diet before the experimental exercise protocol at the second cycle.
- Conditions
- Postbiotics Supplementation
- Being tested
- Postbiotics supplementation, Placebo supplementation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Postbiotics supplementationDietary supplement
The participants will consume one capsule of postbiotics supplement per day
Placebo supplementationDietary supplement
The participants will consume one capsule of placebo per day
| Study group | Role | What they receive |
|---|---|---|
| Postbiotics supplementation | Experimental | Supplementation of postbiotics for 4 weeks Receives: Dietary Supplement: Postbiotics supplementation |
| Placebo supplementation | Placebo comparator | Supplementation of placebo for 4 weeks Receives: Dietary Supplement: Placebo supplementation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in gut microbiota composition
Gut microbiota composition will be assessed in feces
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in butyrate
Butyrate will be assessed in feces
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in propionate
Propionate will be assessed in feces
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in acetate
Acetate will be assessed in feces
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in complete blood count
Complete blood count will be assessed in whole blood
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in creatine kinase activity
Creatine kinase activity will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in TNF-α concentration
TNF-α concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in IL-6 concentration
IL-6 concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in high-sensitivity C-reactive protein concentration
C-reactive protein concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in lipopolysacharides-binding protein concentration
Lipopolysacharides-binding protein concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in zonulin concentration
Zonulin concentration will be assessed in serum and in feces
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in protein carbonyls concentration
Protein carbonyls concentration will be assessed in plasma
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in malondialdehyde concentration
Malondialdehyde concentration will be assessed in plasma
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in reduced glutathione concentration
Glutathione concentration will be assessed in red blood cells lycate
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in oxidized glutathione concentration
Oxidized glutathione concentration will be assessed in red blood cells lycate
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in GSH/GSSG ratio
GSH/GSSG ratio will be assessed in red blood cells lycate
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in catalase concentration
Catalase concentration will be assessed in red blood cells lycate
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in total antioxidant capacity
Total antioxidant capacity will be assessed in red blood cells lycate
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in uric acid concentration
Uric acid concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in bilirubin concentration
Bilirubin concentration will be assessed in serum
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in blood lactate concentration
Bilirubin concentration will be assessed in whole blood
Measured: At baseline (pre), 4 min post-exercise
Changes in delayed onset of muscle soreness in the knee flexors and extensors of both limbs
Muscle soreness of the KF and KE will be assessed via palpation of the muscle belly and the distal regions following 3 squats, and the subjective pain will be recorded on a 10-point scale (1 = no pain, 10 = extreme pain)
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in countermovement jump height
Countermovement jump height will be measured with an optical system
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Changes in isokinetic strength of knee extensors and knee flexors
Isometric, concentric and eccentric peak torque of the knee extensors and knee flexors of both limbs will be assessed on an isokinetic dynamometer
Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2024
- Study start1 Jun 2024
- Primary completion30 Dec 2024
- Study completion30 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postbiotics SupplementationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Thessaly
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Chariklia K. Deli, University of Thessaly
- Investigators
- Chariklia K Deli, PhD, Principal investigator, University of Thessaly
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06428656
- Sponsor's protocol ID
- PB-GM-Exercise-Inflammation
- Acronym
- PostBioExIn
- Status last verified
- Feb 2026
- First submitted
- 20 May 2024
- Last updated
- 4 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Postbiotics Supplementation on Gut Microbiota Composition and Exercise-induced Inflammation
- ClinicalTrials.gov ID
- NCT06428656
- Acronym / sponsor ID
- PostBioExIn / PB-GM-Exercise-Inflammation
- Conditions
- Postbiotics Supplementation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- University of ThessalyUniversity, hospital or other
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 30 Dec 2024 (actual)
- Study completion
- 30 Dec 2024 (actual)
- First posted
- 24 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will investigate the effect of postbiotics supplementation on gut microbiota (GM) composition, exercise-induced oxidative stress and performance following eccentrically biased exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Participants will be randomly assigned into one of the two trials: i) Postbiotics supplementation for 4 weeks, ii) Placebo supplementation for 4 weeks. Participants will then perform a 45-min treadmill running at (-15% slope, ~70% VO2max) followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before, as well as 24 h, 48 h and 72 h following exercise, assessment of GM composition and metabolites (short-chain fatty acids), exercise induced muscle damage (EIMD) (delayed onset of muscle soreness, creatine kinase), complete blood count (CBC), blood inflammatory status (tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), blood redox status (total antioxidant capacity, catalase, protein carbonyls, reduced glutathione, oxidized glutathione, and performance (knee-extensors' and knee-flexors' isometric, concentric, eccentric torque, countermovement jump) will be performed. In addition, metabolism (lactic acid) will be assessed before and 4 min following exercise. Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, the participants will repeat the above procedures under the remaining condition. Between conditions, there will be a 14-day washout period. The results of the research will provide important information for coaches and physically active individuals, regarding the effectiveness of postbiotics to favorably change the gut microbiota composition and alleviate gut inflammation, exercise-induced inflammation and oxidative stress, and improve performance after intense exercise.
Detailed description
Acute, vigorous and/or unaccustomed eccentric exercise can induce muscle injury and inflammatory reactions, and oxidative stress, but also reduced muscle performance. For this reason, many professional as well as amateur athletes, often consume nutritional supplements such as antioxidants, anticipating to reduce inflammation and oxidative stress after intense exercise.
The human gastrointestinal tract is inhabited by various microorganisms, called the gut microbiome (GM). GM, among other things, contributes to the normal functioning of the immune system, contributes to the production of short-chain fatty acids (SCFAs) and vitamin synthesis as well as the digestion and absorption of food, protects against enteropathogens and regulates inflammatory and redox responses. Recent evidence also suggests that GM may be involved in athletic performance. In contrast, disruption of GM composition (dysbiosis) is characterized by reduced diversity, reduced abundance of health-promoting bacteria, and increased abundance of gram-negative and other pathogenic bacteria and is associated with various metabolic diseases such as obesity, diabetes, and various forms of cancer, systemic inflammation, oxidative stress and reduced performance. Thus, the supplementation of several "biotics" has been emerged as a means to regulate the GM in favor of health-promoting bacteria.
Postbiotics is defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Evidence suggests that supplementation with postbiotics may regulate the GM, and consequently, strengthen the immune system, reduce intestinal permeability, improve antioxidant mechanisms, as well as accelerate recovery after exercise-induced inflammation, enhance adaptations to exercise, and improve performance. However, the scientific data regarding the possible beneficial effect of supplemental administration of postbiotics is limited. More research is needed, in order to determine the role of postbiotics supplementation on GM composition and function, exercise-induced inflammation and redox status, but also on performance after intense exercise.
This study will investigate the potential of postbiotics supplementation to alter the GM composition and affect the recovery of exercise-induced oxidative stress and performance following intense, eccentrically biased acute exercise. The study will be cross-over, randomized, double-blind, controlled, and will be conducted in two cycles. The participants, will be primarily informed regarding the study procedures, as well as the benefits and possible risks, and will sign an informed consent form for participation in the study. Before the experimental procedure, they will be involved in a week of familiarization to the evaluation tests and the exercise protocol, at a low intensity. Participants will undergo baseline measurements: anthropometric characteristics (body height, body mass, body mass index) via a stadiometer-scale (Stadiometer 208; Seca, Birmingham, UK), body composition (amount of body fat, lean body mass, fat mass, bone density) via by dual emission X-ray absorptiometry (DXA, GE-Healthcare, Lunar DPX NT, Belgium), aerobic capacity (VO2max) via an automated online pulmonary gas analyzer (Vmax Encore 29, BEBJO296, Yorba Linda, CA, USA) during a graded exercise protocol on a treadmill (Stex 8025T, Korea), isokinetic strength (isometric, concentric and eccentric torque of the knee extensors and knee flexors) on an isokinetic dynamometer (Cybex, HUMAC NORM 360, Ronkonkoma, NY), and muscle power via the assessment of countermovement jump (CMJ) via an optical measurement system (Optojump next, Microgate, USA). In addition, the participants will record their diet via a 7-days recall before their participation in the first experimental condition, and dietary data will be analyzed with ScienceFit Diet 200A diet analysis program (Science Technologies, Athens, Greece), in order to estimate that they do not consume nutrients that may affect muscle injury, inflammation and oxidative stress (e.g. antioxidants, etc.). Participants will then be randomized in one of the two conditions: i) Postbiotics supplementation (50mg/day of Heatkilled Lactobacillus plantarum L-137, Immuno-LP20TM) for 4 weeks, or ii) placebo supplementation for 4 weeks. Randomization of the conditions will be done by a software generating random integers available on the internet (Random.org). Participants will then perform an exercise protocol comprised of 45 min downhill running (-15% slope, ~70-75% VO2max) on a treadmill followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before the exercise protocol, as well as 24 h, 48 h and 72 h after exercise, exercise-induced muscle damage (EIMD) [delayed onset of muscle soreness (DOMS) via palpation of the knee extensors and knee flexors on a scale of 1 to 10 (1 = no pain at all; 10 = extreme pain), and muscle performance (CMJ, isometric, concentric and eccentric torque of the knee extensors and knee flexors)], will be assessed. At the same time points, feces samples will be collected for the analysis of GM composition and function, and GM metabolites, as well as blood samples for the assessment of complete blood count (CBC), blood inflammatory status (creatine kinase, tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), and blood redox status [reduced glutathione (GSH), oxidized glutathione (GSSG), GSH/GSSG ratio, total antioxidant capacity, catalase, protein carbonyls, uric acid, bilirubin). Furthermore, metabolism (lactic acid) will be assessed before and 4 min following exercise by analyzing capillary blood with a portable lactate analyzer (Lactate Plus, Nova Biomedical, USA). Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, participants will repeat the exact same procedures for the remaining condition. Between cycles, a 14-days washout period will be applied. Additionally, the 7-day diet recall from the first cycle, will be given to the participants to follow the same diet before the experimental exercise protocol at the second cycle.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Postbiotics supplementation | Experimental | Dietary Supplement: Postbiotics supplementationSupplementation of postbiotics for 4 weeks |
| Placebo supplementation | Placebo comparator | Dietary Supplement: Placebo supplementationSupplementation of placebo for 4 weeks |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Physically active subjects (VO2max ≥35ml/kg/min)
- Absence of musculoskeletal injury (≥6 months)
- Abstinence from the use of ergogenic supplements (≥1 month)
- Abstinence from anti-inflammatory drugs (≥1 month)
- Abstinence from pre-pro-postbiotic supplements (≥6 months)
Key exclusion criteria (6 listed)
- Recent history of musculoskeletal injury (<6 months)
- Use of ergogenic performance supplements (<1 month)
- Taking anti-inflammatory drugs (<1 month)
- Taking pre-pro-postbiotic supplements (<6 months)
- Participation in exercise with eccentric content in the previous 7 days before exercise
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Postbiotics supplementationThe participants will consume one capsule of postbiotics supplement per day | Dietary supplement | Postbiotics supplementation |
| Placebo supplementationThe participants will consume one capsule of placebo per day | Dietary supplement | Placebo supplementation |
Primary outcome
Changes in gut microbiota composition
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Gut microbiota composition will be assessed in feces
Changes in butyrate
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Butyrate will be assessed in feces
Changes in propionate
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Propionate will be assessed in feces
Changes in acetate
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Acetate will be assessed in feces
Changes in complete blood count
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Complete blood count will be assessed in whole blood
Changes in creatine kinase activity
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Creatine kinase activity will be assessed in serum
Changes in TNF-α concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
TNF-α concentration will be assessed in serum
Changes in IL-6 concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
IL-6 concentration will be assessed in serum
Changes in high-sensitivity C-reactive protein concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
C-reactive protein concentration will be assessed in serum
Changes in lipopolysacharides-binding protein concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Lipopolysacharides-binding protein concentration will be assessed in serum
Changes in zonulin concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Zonulin concentration will be assessed in serum and in feces
Changes in protein carbonyls concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Protein carbonyls concentration will be assessed in plasma
Changes in malondialdehyde concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Malondialdehyde concentration will be assessed in plasma
Changes in reduced glutathione concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Glutathione concentration will be assessed in red blood cells lycate
Changes in oxidized glutathione concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Oxidized glutathione concentration will be assessed in red blood cells lycate
Changes in GSH/GSSG ratio
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
GSH/GSSG ratio will be assessed in red blood cells lycate
Changes in catalase concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Catalase concentration will be assessed in red blood cells lycate
Changes in total antioxidant capacity
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Total antioxidant capacity will be assessed in red blood cells lycate
Changes in uric acid concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Uric acid concentration will be assessed in serum
Changes in bilirubin concentration
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Bilirubin concentration will be assessed in serum
Changes in blood lactate concentration
Time frame: At baseline (pre), 4 min post-exercise
Bilirubin concentration will be assessed in whole blood
Changes in delayed onset of muscle soreness in the knee flexors and extensors of both limbs
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Muscle soreness of the KF and KE will be assessed via palpation of the muscle belly and the distal regions following 3 squats, and the subjective pain will be recorded on a 10-point scale (1 = no pain, 10 = extreme pain)
Changes in countermovement jump height
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Countermovement jump height will be measured with an optical system
Changes in isokinetic strength of knee extensors and knee flexors
Time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise
Isometric, concentric and eccentric peak torque of the knee extensors and knee flexors of both limbs will be assessed on an isokinetic dynamometer
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Feb 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chariklia K Deli, PhD principal investigator
University of Thessaly
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Postbiotics supplementation in people with Postbiotics Supplementation, run by University of Thessaly at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in gut microbiota composition (time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise). The study lists 24 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026; AzTrials last refreshed its copy on 29 Oct 2026.